F

Franciscan Health | Indiana Blood and Marrow Transplantation

Research site

(Unclaimed)

Location

8111 S. Emerson Avenue Suite 207, Indianapolis, Indiana, United States of America

Site insights

Top conditions

Top treatments

Bosutinib

Ruxolitinib

INCB050465

PF-06863135

VRx-3996

Ibrutinib

Oxaliplatin

Bendamustine

Elranatamab

Tafasitamab

Parent organization

This site is a part of Franciscan Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 25 total trials

A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) (EPCORE DLBCL-1)

The purpose of this trial is to find out if epcoritamab, also known as EPKINLY™ and GEN3013, is safe and works well as treatment for participants wit...

Active, not recruiting

Diffuse Large B-cell Lymphoma

Drug: Investigator's Choice Chemotherapy

Biological: Epcoritamab

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL (ALPHA3)

This is a randomized, open-label study in adult patients who have completed standard first line therapy for large B-cell lymphoma (LBCL) and achieved...

Enrolling

Large B-cell Lymphoma

Drug: Fludarabine

Genetic: cemacabtagene ansegedleucel

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of rondecabtagene autoleucel (ronde-cel) also known as LYL314,...

Enrolling

Relapsed Non-Hodgkin Lymphoma

Large B-cell Lymphoma

Drug: Rondecabtagene autoleucel (ronde-cel)

Drug: Fludarabine